common.study.topics.clinical

Predicting Hypoventilation Due to an Opioid Overdose

common.study.values.description

Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose

RTM Vital Signs, LLC is developing a miniature wearable tracheal sound sensor that communicates with a cell phone containing a machine-learning diagnostic algorithm designed to detect and predict the onset of mild, moderate, and severe hypoventilation (respiratory depression) due to an opioid overdose. The purpose of this clinical trial is to develop/validate diagnostic algorithms capable of detecting/predicting the onset of hypoventilation induced by a controlled intravenous infusion of fentanyl. The wearable sensor and algorithms will provide a series of alerts and alarms to the person, caregiver, and/or emergency personnel.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Device - Diagnostic algorithms that detects/predicts hypoventilation

Produce mild and moderate respiratory depression (hypoventilation) using a controlled intravenous infusion of fentanyl while measuring/recording respiratory rate, tidal volume, body activity, and body position.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose

common.study.values.clinical-trial-id

NCT03845699

participant.views.study.view.id

b82z2e